These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33622150)

  • 21. Treatment of Axillary Bromhidrosis with Topical 2% Glycopyrronium Bromide Cream: A Prospective, Non-randomized, Open-label Study.
    Gregoriou S; Markantoni V; Campanati A; Martina E; Offidani A; Kouris A; Platsidaki E; Bokotas H; Stratigos A; Rigopoulos D; Kontochristopoulos G
    J Clin Aesthet Dermatol; 2021 Nov; 14(11):E61-E63. PubMed ID: 34980961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis.
    Glaser DA; Pariser DM; Hebert AA; Landells I; Somogyi C; Weng E; Brin MF; Beddingfield F
    Pediatr Dermatol; 2015; 32(5):609-17. PubMed ID: 26059781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shortening of Incision by "Pinch and Turn-Over Technique" in the Treatment of Axillary Osmidrosis.
    Lee ET
    Aesthetic Plast Surg; 2019 Feb; 43(1):267-277. PubMed ID: 30413844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with Botulinum toxin A.
    He J; Wang T; Dong J
    J Dermatolog Treat; 2012 Dec; 23(6):461-4. PubMed ID: 21801111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excision of apocrine glands with preservation of axillary superficial fascia for the treatment of axillary bromhidrosis.
    Li ZR; Sun CW; Zhang JY; Qi YQ; Hu JZ
    Dermatol Surg; 2015 May; 41(5):640-4. PubMed ID: 25874360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological Changes in Axillary Hyperhidrosis and Axillary Osmidrosis Induced by Microwave Treatment: Comparison of Single- and Double-Pass Irradiation.
    Hatano T; Fukasawa N; Miyano C; Wiederkehr I; Miyawaki T
    Lasers Surg Med; 2021 Nov; 53(9):1220-1226. PubMed ID: 34036606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of axillary bromhidrosis in adolescents by combining electrocauterization with ultrasound-guided botulinum toxin type A injection.
    Chen W; Zhang X; Zhang L; Xu Y
    J Plast Reconstr Aesthet Surg; 2021 Nov; 74(11):3114-3119. PubMed ID: 34238698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refined tumescent liposuction-curettage with pruning in small incisions for treatment of axillary bromhidrosis.
    Li CY; Wang XF; Zhou HY; Fang QQ; Tan WQ
    Dermatol Ther; 2021 Jan; 34(1):e14690. PubMed ID: 33342012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
    Hebert AA; Glaser DA; Green L; Werschler WP; Forsha DW; Drew J; Gopalan R; Pariser DM
    Pediatr Dermatol; 2019 Jan; 36(1):89-99. PubMed ID: 30451318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.
    Pariser DM; Hebert AA; Drew J; Quiring J; Gopalan R; Glaser DA
    Am J Clin Dermatol; 2019 Feb; 20(1):135-145. PubMed ID: 30378087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumescent superficial liposuction with curettage for treatment of axillary bromhidrosis.
    Seo SH; Jang BS; Oh CK; Kwon KS; Kim MB
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):30-5. PubMed ID: 18181970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumescent liposuction with dermal curettage for treatment of axillary osmidrosis and hyperhidrosis.
    Lee D; Cho SH; Kim YC; Park JH; Lee SS; Park SW
    Dermatol Surg; 2006 Apr; 32(4):505-11; discussion 511. PubMed ID: 16681657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-week prospective observational study of 5% sofpironium bromide gel in Japanese patients with primary axillary hyperhidrosis.
    Fujimoto T; Okatsu H; Miyama H
    J Dermatol; 2022 Jun; 49(6):594-599. PubMed ID: 35394087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy of microwave in the treatment of axillary osmidrosis and primary hyperhidrosis.
    Zhang Y; Gong YY; Tang YL; Bai YS; Yang K; Chen HY; Zhang QA; Wang JA; Zhu YF; Li HY; Liu QM; Lin JR; Wu WY
    Dermatol Ther; 2022 Aug; 35(8):e15657. PubMed ID: 35726636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How We Do It: Image-Guided Microwave-Based Therapy for Axillary Hyperhidrosis and Osmidrosis.
    Huang YL; Hu S; Cheng CY
    Dermatol Surg; 2021 May; 47(5):738-739. PubMed ID: 33905401
    [No Abstract]   [Full Text] [Related]  

  • 36. Sparing subcutaneous septa avoids skin necrosis in the treatment of axillary bromhidrosis with suction-curettage shaving.
    Hsu KC; Wang KY
    J Cosmet Dermatol; 2019 Jun; 18(3):892-896. PubMed ID: 30094912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A survey of patient satisfaction with use of microwave device for axillary hyperhidrosis.
    Scuderi S; Manoharan P; Lim D; Manoharan S
    Australas J Dermatol; 2017 May; 58(2):126-129. PubMed ID: 26802036
    [No Abstract]   [Full Text] [Related]  

  • 38. Endoscopic surgical treatment of bromhidrosis: a report of 18 consecutive patients from 2010 to 2013.
    Hu X; Zhang Y; Miao X; Dou H; Zhang K; Zhou X; Wang T
    J Laparoendosc Adv Surg Tech A; 2014 May; 24(5):323-7. PubMed ID: 24654700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous ethanol injection as a promising and minimally invasive treatment for axillary osmidrosis: Double-blinded randomized controlled trial.
    Asilian A; Shahbazi M; Abtahi-Naeini B; Poostiyan N; Nilforoushzadeh MA
    Indian J Dermatol Venereol Leprol; 2018; 84(2):157-162. PubMed ID: 29393079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.
    Müller C; Berensmeier A; Hamm H; Dirschka T; Reich K; Fischer T; Rzany B
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1278-84. PubMed ID: 23004926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.